| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0008 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |